ReviewIndian journal of pediatrics2025
Fluid Management in ELGANs: Striking the Perfect Balance!
Review in Indian journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Time to diagnosis of acute kidney injury and its predictors among outborn neonates in India: a competing-risk analysis of tele-ICU network data (2022-2024).The Lancet regional health. Southeast Asia · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Managing fluid and electrolytes in extremely low gestational age neonates (ELGANs) is often challenging because of their distinctive fluid physiology. Most of the fluid loss in the first week of life is trans-epidermal due to the immature barrier function of the skin. ELGANs also have a developmental tendency for exaggerated diuresis and natriuresis. Allowing an initial weight loss of 6-12% promotes physiological extracellular contraction. Also, restricted fluid intake in the first week of life may decrease the incidence of bronchopulmonary dysplasia, patent ductus arteriosus, and necrotizing enterocolitis. A protocol-based approach for fluid management in ELGANs, developed based on physiology and available evidence, is the best strategy. Based on the estimated dermal and renal losses and desired weight change, the authors recommend initiating total fluids on the first day of life at 100 mL/kg/d in neonates at 26-27 wk gestation and 110 mL/kg/d at 24-25 wk gestation. The subsequent fluid rate is determined based on rigorous monitoring of weight, urine output, and serum sodium, with a typical daily increment in fluids of 10-20 mL/kg and a maximum fluid rate of 150-160 mL/kg/d in 26-27 wk and 160-180 mL/kg/d in 24-25 wk gestation neonates by day 7 of life. Fluid strategy should ideally be revised every 12 h in the first few days of life. A humidified incubator is the ideal care environment to minimize trans-epidermal losses. Since most of these recommendations are not based on concrete evidence from trials, it is advisable to periodically audit the outcomes and devise a unit-specific fluid strategy.
Indexed as
Identifiers
39903354What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.